Northwest & Ethical Investments’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
+9,394
| New | +$2.06M | 0.05% | 251 |
|
|
2022
Q4 | – | Sell |
-2,367
| Closed | -$582K | – | 430 |
|
|
2022
Q3 | $582K | Sell |
2,367
-64
| -3% | -$15.7K | 0.02% | 341 |
|
|
2022
Q2 | $735K | Buy |
2,431
+447
| +23% | +$135K | 0.03% | 327 |
|
|
2022
Q1 | $815K | Sell |
1,984
-491
| -20% | -$202K | 0.03% | 317 |
|
|
2021
Q4 | $1.16M | Buy |
2,475
+638
| +35% | +$299K | 0.03% | 286 |
|
|
2021
Q3 | $780K | Buy |
+1,837
| New | +$780K | 0.03% | 316 |
|
|
2021
Q1 | – | Sell |
-8,847
| Closed | -$2.51M | – | 436 |
|
|
2020
Q4 | $2.51M | Hold |
8,847
| – | – | 0.1% | 223 |
|
|
2020
Q3 | $2.43M | Buy |
8,847
+2,767
| +46% | +$761K | 0.11% | 219 |
|
|
2020
Q2 | $1.38M | Buy |
+6,080
| New | +$1.38M | 0.07% | 276 |
|